Identification of a broad sarbecovirus neutralizing antibody targeting a conserved epitope on the receptor-binding domain
Description
Omicron, as the emerging variant with enhanced vaccine tolerance, has sharply disrupted most therapeutic antibodies. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) belongs to the subgenus Sarbecovirus, members of which share high